AGIOS PHARMACEUTICALS, INC. ($AGIO)
Filing Information
| Accession Number | 0001439222-26-000042 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
14
Total Shares
106,390
Total Value
$151,113.28
P&L
+inf% (+$1,838,760.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 35,718 | Direct | โ | View Details | |
Chief Legal Officer | Common stock | โ | Mar 2, 2026 | Sale | 1,187 | $28.96 | $34,375.52 | 34,531 | Direct | โ | View Details | |
Chief Legal Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 5,666 | $0.00 | $0.00 | 40,197 | Direct | โ | View Details | |
Chief Legal Officer | Common stock | โ | Mar 2, 2026 | Sale | 1,681 | $28.96 | $48,681.76 | 38,516 | Direct | โ | View Details | |
Chief Legal Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 42,516 | Direct | โ | View Details | |
Chief Legal Officer | Common stock | โ | Mar 2, 2026 | Sale | 1,187 | $28.96 | $34,375.52 | 41,329 | Direct | โ | View Details | |
Chief Legal Officer | Common stock | โ | Mar 2, 2026 | Exercise/Conversion | 3,920 | $0.00 | $0.00 | 45,249 | Direct | โ | View Details | |
Chief Legal Officer | Common stock | โ | Mar 2, 2026 | Sale | 1,163 | $28.96 | $33,680.48 | 44,086 | Direct | โ | View Details | |
Chief Legal Officer | Restricted stock units | Derivative | Mar 1, 2026 | Grant/Award | 14,000 | $0.00 | $0.00 | 14,000 | Direct | โ | View Details | |
Chief Legal Officer | Stock options (right to buy) | Derivative | Mar 1, 2026 | Grant/Award | 52,000 | $0.00 | $0.00 | 52,000 | Direct | โ | View Details | |
Chief Legal Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Legal Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 5,666 | $0.00 | $0.00 | 5,667 | Direct | โ | View Details | |
Chief Legal Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 4,000 | $0.00 | $0.00 | 8,000 | Direct | โ | View Details | |
Chief Legal Officer | Restricted stock units | Derivative | Mar 2, 2026 | Exercise/Conversion | 3,920 | $0.00 | $0.00 | 7,839 | Direct | โ | View Details |